Laniquidar ( R-101933;R101933 )

Catalog No. M13087 CAS No. 197509-46-9

An orally active, third-generation P-glycoprotein inhibitor that inhibits the drug efflux pump P-glycoprotein.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	1089	Get Quote
50MG	1782	Get Quote
100MG	2250	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Laniquidar
Note

Research use only, not for human use.
Brief Description

An orally active, third-generation P-glycoprotein inhibitor that inhibits the drug efflux pump P-glycoprotein.
Description

An orally active, third-generation P-glycoprotein inhibitor that inhibits the drug efflux pump P-glycoprotein, resulting in higher concentrations of antineoplastic agents in tumor cells that are multi-drug resistant due to the overexpression of P-glycoprotein.Breast Cancer Phase 2
Synonyms

R-101933;R101933
Pathway

Membrane Transporter/Ion Channel
Target

P-glycoprotein
Recptor

P-glycoprotein
Research Area

Cancer
Indication

Breast Cancer

Chemical Information

CAS Number

197509-46-9
Formula Weight

584.70
Molecular Formula

C37H36N4O3
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C(C1=CN=C2N1CCC3=CC=CC=C3/C2=C4CCN(CCC5=CC=C(OCC6=NC7=CC=CC=C7C=C6)C=C5)CC\4)OC
Chemical Name

methyl 11-(1-(4-(quinolin-2-ylmethoxy)phenethyl)piperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepine-3-carboxylate

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. van Zuylen L, et al. Clin Cancer Res. 2000 Apr;6(4):1365-71.
2. van Zuylen L, et al. Eur J Cancer. 2002 May;38(8):1090-9.
3. Luurtsema G, et al. Nucl Med Biol. 2009 Aug;36(6):643-9.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks